Fish Oil Reduces Cardiovascular Events

Dr. Carl (Chip) Lavie, Professor of Medicine in the Department of Cardiovascular Diseases at the John Ochsner Heart and Vascular Institute, Ochsner Clinical School and the University of Queensland School of Medicine in New Orleans, Louisiana, and Section Editor for Cardiovascular Diseases for Mayo Clinic Proceedings, Along with his coauthors including Dr. James DiNicholantonio, reviews his article appearing in the December 2019 issue of Mayo Clinic Proceedings, which examined the outcomes of 3 large trials and found fish oil consumption to be associated with the benefit of reduction of mortality risk in cardiovascular disease. Available at:

Mayo Clinic Proceedings,Omega 3,DHA,Docosahexaenoic Acid,DPA,Docosapentaenoic Acid. EPA,Eicosapentaenoic Acid,hsCRP,High-sensitivity C-reactive Protein,IPE,Icosapent Ethyl,LDL-C,Low-density Lipoprotein Cholesterol,Major Adverse CV Events,Myocardial Infarction,Percutaneous Coronary Revascularization,Polyunsaturated Fatty Acid,Triglyceride,